NewGenIvf Group Limited (NIVF) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
NewGenIvf Group Limited (NIVF) Earnings Overview
As of June 25, 2026, NewGenIvf Group Limited (NIVF) reported trailing twelve-month net income of -$461,617, reflecting +175.3% year-over-year growth. The company earned $-0.78 per diluted share over the past four quarters, with a net profit margin of 209.0%.
Looking at the long-term picture, NIVF's historical earnings data spans multiple years. The company achieved its highest annual net income of $10M in fiscal 2025, representing a new all-time high.
NewGenIvf Group Limited is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including NTRA (-$226M net income, -9.0% margin), PGNY ($68M net income, 4.5% margin), TMHC ($672M net income, 9.6% margin), NIVF has outperformed on profitability metrics. Compare NIVF vs NTRA →
NIVF Earnings vs Peers
Earnings metrics vs comparable public companies
NIVF Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $10M | +1981.8% | -$11M | $16.80 | 209.0% | -226.9% |
| 2024 | $-525,000 | -503.2% | -$1M | $-22.31 | -9.7% | -21.4% |
| 2023 | $130,193 | -71.6% | $42,242 | $12.44 | 2.5% | 0.8% |
| 2022 | $458,667 | +86153.8% | $-504,907 | $62.52 | 7.7% | -8.5% |
| 2021 | $-533 | - | $198,758 | $-0.00 | -0.0% | 4.8% |
Download Data
Export NIVF earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
NIVF — Frequently Asked Questions
Quick answers to the most common questions about buying NIVF stock.
What is NIVF earnings per share (EPS)?
NIVF trailing twelve-month (TTM) diluted EPS is $-0.78, reflecting +175.3% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is NewGenIvf Group Limited's net income?
NewGenIvf Group Limited (NIVF) trailing twelve-month net income is $-461617.00 as of 2025. Earnings grew +175.3% year-over-year.
Is NIVF profitable?
NIVF is not currently profitable on a TTM basis, reporting a net loss of $-461617.00. Net margin is +209.0%. Investors should monitor for a return to profitability.
What is NIVF's earnings growth rate?
NIVF compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: -35.5%, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are NIVF's profit margins?
NewGenIvf Group Limited net profit margin is +209.0%, operating margin is -226.9%, and gross margin is +20.2%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +80.6%.
Is NIVF growing earnings?
Yes, NIVF earnings are accelerating — EPS growth of +175.3% exceeds the 5-year CAGR of N/A. TTM net income reached $-461617.00. Earnings momentum is strengthening.
What was NIVF's best earnings year?
NewGenIvf Group Limited's highest annual net income on record is $10M, achieved in fiscal year 2025. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were NIVF's earnings last quarter?
NIVF's most recent reported quarter was Q4 2024. Net income was $-108000.00 with diluted EPS of $-4.60. For a full breakdown of all quarters, see the quarterly earnings table on this page.